Ginkgo Bioworks Holdings, Inc. (DNA)

USD 7.04

(1.15%)

Net Debt Summary of Ginkgo Bioworks Holdings, Inc.

  • Ginkgo Bioworks Holdings, Inc.'s latest annual net debt in 2023 was -707.09 Million USD , up 19.02% from previous year.
  • Ginkgo Bioworks Holdings, Inc.'s latest quarterly net debt in 2024 Q2 was -280.45 Million USD , up 54.35% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported annual net debt of -873.2 Million USD in 2022, up 42.81% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported annual net debt of -1.52 Billion USD in 2021, down -319.73% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported quarterly net debt of -609.27 Million USD for 2024 Q1, up 13.83% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported quarterly net debt of -707.09 Million USD for 2023 FY, up 19.02% from previous quarter.

Annual Net Debt Chart of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Historical Annual Net Debt of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Year Net Debt Net Debt Growth
2023 -707.09 Million USD 19.02%
2022 -873.2 Million USD 42.81%
2021 -1.52 Billion USD -319.73%
2020 -363.79 Million USD 23.97%
2019 -478.52 Million USD 0.0%
2001 -902.53 Million USD 0.0%

Peer Net Debt Comparison of Ginkgo Bioworks Holdings, Inc.

Name Net Debt Net Debt Difference
ADC Therapeutics SA -154.22 Million USD -358.494%
Alto Neuroscience, Inc. 68.91 Million USD 1126.038%
Annovis Bio, Inc. -5.75 Million USD -12187.201%
Biohaven Pharmaceutical Holding Company Ltd. -218.84 Million USD -223.106%
Nuvation Bio Inc. -38.64 Million USD -1729.859%
Nuvation Bio Inc. -38.64 Million USD -1729.859%
Arcus Biosciences, Inc. -116 Million USD -509.564%
Zymeworks Inc. -130.83 Million USD -440.447%